Correlation Between Dianthus Therapeutics and Pyxis Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Pyxis Oncology, you can compare the effects of market volatilities on Dianthus Therapeutics and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Pyxis Oncology.

Diversification Opportunities for Dianthus Therapeutics and Pyxis Oncology

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dianthus and Pyxis is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Pyxis Oncology go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Pyxis Oncology

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Pyxis Oncology. In addition to that, Dianthus Therapeutics is 1.52 times more volatile than Pyxis Oncology. It trades about -0.15 of its total potential returns per unit of risk. Pyxis Oncology is currently generating about -0.16 per unit of volatility. If you would invest  169.00  in Pyxis Oncology on October 21, 2024 and sell it today you would lose (19.00) from holding Pyxis Oncology or give up 11.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dianthus Therapeutics  vs.  Pyxis Oncology

 Performance 
       Timeline  
Dianthus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Pyxis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dianthus Therapeutics and Pyxis Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dianthus Therapeutics and Pyxis Oncology

The main advantage of trading using opposite Dianthus Therapeutics and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.
The idea behind Dianthus Therapeutics and Pyxis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities